Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

3rd Immunotherapy of Cancer Conference (ITOC3)

21 - 23 Mar 2016
Munich Tumour Centre, Munich, Germany
Immunology highlights from the ITOC-3 conference
Prof Heinz Zwierzina - Innsbruck University, Innsbruck, Austria
Immunology highlights from the ITOC-3 conference ( Prof Heinz Zwierzina - Innsbruck University, Innsbruck, Austria )
12 Apr 2016
Novel technologies for understanding the repertoire of tumour infiltrating T cel...
Prof Sine Reker Hadrup - Technical University of Denmark, Kongens Lyngby, Denmar...
Novel technologies for understanding the repertoire of tumour infiltrating T cells in cancer ( Prof Sine Reker Hadrup - Technical University of Denmark, Kongens Lyngby, Denmark )
7 Apr 2016
Targeting AFP in hepatocellular cancer
Dr Lisa Butterfield University of Pittsburgh, Pittsburgh, USA
Targeting AFP in hepatocellular cancer ( Dr Lisa Butterfield University of Pittsburgh, Pittsburgh, USA )
5 Apr 2016
Combination of viroimmunotherapy with checkpoint inhibitors
Prof Alan Melcher - The Institute of Cancer Research and The Royal Marsden Hospi...
Combination of viroimmunotherapy with checkpoint inhibitors ( Prof Alan Melcher - The Institute of Cancer Research and The Royal Marsden Hospital, London, UK )
4 Apr 2016
Is PD-L1 really a predictive biomarker?
Dr Paolo Ascierto - National Tumor Institute, Naples, Italy
Is PD-L1 really a predictive biomarker? ( Dr Paolo Ascierto - National Tumor Institute, Naples, Italy )
4 Apr 2016
Patient perspective on immunotherapy and the ITOC-3 conference
Peter Trayhurn - Patient advocate
Patient perspective on immunotherapy and the ITOC-3 conference ( Peter Trayhurn - Patient advocate )
4 Apr 2016
Hypoxia and its impact on the immune system
Dr Luigi Varesio - Giannina Gaslini Institute, Genova, Italy
Hypoxia and its impact on the immune system ( Dr Luigi Varesio - Giannina Gaslini Institute, Genova, Italy )
4 Apr 2016
The role of microRNAs in modulation of the immune escape of tumors
Dr Barbara Seliger - Universitätsklinikum Halle , Saale, Germany
The role of microRNAs in modulation of the immune escape of tumors ( Dr Barbara Seliger - Universitätsklinikum Halle , Saale, Germany )
4 Apr 2016
Reprogramming the cancer microenvironment with vaccine-based therapy
Prof Lei Zheng - John Hopkins Institute Baltimore, USA
Reprogramming the cancer microenvironment with vaccine-based therapy ( Prof Lei Zheng - John Hopkins Institute Baltimore, USA )
4 Apr 2016
T cells expressing two additional receptors (TETARs) for the use in a multiple- ...
Dr Gerold Schuler - Universitätsklinikum, Erlangen, Germany
T cells expressing two additional receptors (TETARs) for the use in a multiple- hit immunotherapy ( Dr Gerold Schuler - Universitätsklinikum, Erlangen, Germany )
4 Apr 2016
Biomarkers in t-cell therapy trials
Dr Jérôme Galon - Laboratory of Integrative Cancer Immunology, Paris, France
Biomarkers in t-cell therapy trials ( Dr Jérôme Galon - Laboratory of Integrative Cancer Immunology, Paris, France )
4 Apr 2016
Immunotherapy and personalised medicine in review
Prof Paul Sondel - University of Wisconsin, Madison, USA
Immunotherapy and personalised medicine in review ( Prof Paul Sondel - University of Wisconsin, Madison, USA )
4 Apr 2016
Rationale for combining immunotherapy with chemotherapy
Prof Angus Dalgleish - St. Georges University, London UK
Rationale for combining immunotherapy with chemotherapy ( Prof Angus Dalgleish - St. Georges University, London UK )
1 Apr 2016
Targeting tumour vasculature by DNA vaccines
Dr Andrea Facciabene - University of Pennsylvania, Philadelphia, USA
Targeting tumour vasculature by DNA vaccines ( Dr Andrea Facciabene - University of Pennsylvania, Philadelphia, USA )
1 Apr 2016